Preview Mode Links will not work in preview mode

Clinical Literature Summaries presented by InpharmD™ (S3)

Apr 21, 2022

A multicenter, randomized, open label, non-inferiority trial conducted to test and compare the efficacy of methenamine hippurate for prevention of recurrent urinary tract infections (UTI) with the current standard prophylaxis of daily low dose antibiotics.